UAE In-Vitro Fertilization Market: Female Infertility Rate of 90% Driving Demand
UAE In-Vitro Fertilization Market
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "UAE In-Vitro Fertilization Market By Technique, By Reagent, By Instrument, By Infertility, By Embryo, By Application, By End-User, By Region, Competition, Forecast & Opportunities, 2017-2027" report has been added to ResearchAndMarkets.com's offering.
UAE In-Vitro Fertilization (IVF) market stood at USD 231.57 Million in 2021 and is expected to reach a CAGR of 9.64% during the forecast period. The rise in genetic disorders in newly born babies of UAE have led most couples to adopt in-vitro fertilization (IVF) treatment to produce healthy and normal babies.
Growing Medical Tourism for Fertility Treatments in UAE
In the recent times, UAE has established its position as the world's leading country for medical tourists offering a variety of state-of-the-art technology, best physicians, and medical procedures at an affordable range.
UAE offers world class fertility treatment amalgamated with several other amenities such as gynecology consultation, diagnostic tests, etc. Moreover, there are many services such as the ease of gender selection or family balancing, where the family can select the gender of their baby, available in UAE which are otherwise prohibited or unavailable in other countries. Moreover, UAE offers the facility to test the overall chromosomal normalcy in embryos. This test allows for the detection of any genetic disorder that could be running in the family since the ancestral times.
Besides, UAE is also known for high success rates for IVF treatments due to the presence of skilled ART technicians, embryologists and fertility centers which is making UAE the most preferred destination for reproductive tourism. Furthermore, UAE has relaxed the tourist/medical visa eligibility and provides visa on arrival for numerous countries, driving the attention of tourists from various parts of the world.
Rising Female Infertility in UAE
In United Arab Emirates, female infertility is reported to be about 90%. The foremost reason for this is the lack of exposure to sun. Females in Emirati cities such as Dubai, Abu Dhabi, Sharjah, and Al Ain wear a burqa or abaya whenever they step out of their houses. Reduced sun exposure results in decreased vitamin D levels in the female body. Vitamin D levels help to promote the production of anti-Mullerian hormone (AMH) which is essential in maintaining the egg number and egg quality in females. As a result of which, most women in UAE face fertility issues because of deteriorated egg number and egg quality. Diminished levels of vitamin D can cause high levels of cholesterol in women which can again hinder the pregnancy.
Another common cause for infertility in Emirati women is obesity. Obesity is another prevalent condition in females of UAE which causes a decrease in uterus receptivity and subsided quality of egg. In addition, cases with secondary infertility in which there are problems in getting pregnant after having conceived the first time, are also high.
Gender Selection/Family Balancing
Through IVF and Comprehensive Chromosomal Screening (CCS), also known as pre-implantation genetic diagnosis, it may be feasible to determine the gender of the embryos prior to pregnancy thanks to recent advancements in reproductive technology. In order to achieve a more balanced representation of both genders in a home, expectant parents in the UAE frequently disclose the gender of their kid. Additionally, next generation sequencing (NGS) and IVF work together to produce results that are approximately 100% correct at the chromosomal level, making family balancing safe & efficient for expectant parents.
The growing awareness of the importance of early detection of chromosomal disorders such as Down syndrome and Edward's syndrome is also fueling the expansion of the IVF industry. Due to this underlying reason, UAE is a fast-growing country in adopting In-Vitro Fertilization (IVF) to produce healthy babies with a choice of family balancing, thus positively impacting the IVF market in UAE.
Report Scope
UAE In-Vitro Fertilization (IVF) Market, By Technique:
ICSI IVF
Non-ICSI/Traditional IVF
UAE In-Vitro Fertilization (IVF) Market, By Reagent:
Embryo Culture Media
Cryopreservation Media
Sperm Processing Media
Ovum Processing Media
UAE In-Vitro Fertilization (IVF) Market, By Instruments:
Imaging Systems
Sperm Separation Systems
Ovum Aspiration Pumps
Incubators
Micromanipulator Systems
Cryo-systems
Others
UAE In-Vitro Fertilization (IVF) Market, By Infertility:
Female
Male
UAE In-Vitro Fertilization (IVF) Market, By Embryo:
Frozen-Thawed Embryo
Fresh Embryo
UAE In-Vitro Fertilization (IVF) Market, By Application:
Fertility Clinics
Hospitals
Others
UAE In-Vitro Fertilization (IVF) Market, By End-User:
Locals
Expats
Medical Tourists
UAE In-Vitro Fertilization (IVF) Market, By Region:
Abu Dhabi
Dubai
Sharjah
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on UAE In-Vitro Fertilization (IVF) Market
4. Executive Summary
5. Voice of Customer
6. UAE In-Vitro Fertilization (IVF) Market Outlook
7. Abu Dhabi In-Vitro Fertilization (IVF) Market Outlook
8. Dubai In-Vitro Fertilization (IVF) Market Outlook
9. Sharjah In-Vitro Fertilization (IVF) Market Outlook
10. Market Dynamics
11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. UAE Economic Profile
14. Pricing Analysis of IVF Treatment in UAE
15. Competitive Landscape
16. Strategic Recommendations
Companies Mentioned
Fakih IVF Fertility Center
First IVF Fertility Center
HelpPlus Fertility Centre
The Dubai Center for Gynecology and Fertility
New Hope IVF
Select IVF
Bourn Hall Fertility Clinic
HealthPlus Fertility Center
Burjeel Hospital
ART Fertility Clinics
For more information about this report visit https://www.researchandmarkets.com/r/le10c9
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900